Fig. 4. Decreased cell proliferation ability by the downregulation of FLRT3.
(A) Lung cancer and (B) Lung cancer-derived stem cell. Data shown represent the mean ± SD (n=3). ***P < 0.001, and *P < 0.05 compared with 0 h.

Biomed Sci Letters 2023;29:336-43 https://doi.org/10.15616/BSL.2023.29.4.336

© 2023 Biomed Sci Letters